Eli Lilly (LLY)Sen. Alan Armstrong disclosed a sale $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

116 days

Disclosure lag

Traded

Mar 27, 2026

Disclosed

Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 29, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
2. Jan 16, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
3. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
4. Feb 9, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
5. Feb 13, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
6. Feb 26, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
7. Mar 13, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
8. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
9. Mar 27, 2026 · this disclosureCongressDisclosed sale of LLY — reported range $1,001 - $15,000

What came next

1. Apr 1, 2026FDAFDA drug approval: Foundayo
2. Apr 2, 2026Congress · 1 personMembers of Congress: 2 purchases
3. Apr 8, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
4. Apr 14, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
5. Apr 20, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.7%
6. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
7. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.5%
8. May 6, 2026Insider · 1 personInsiders: 2 sales (~$15.8M)
9. May 15, 2026Federal contract · $52K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $52K obligated to date
10. Jun 9, 2026FDAFDA drug approval: Ebglyss
11. Jun 10, 2026Insider · Their largest sale since 2022Officer sold ~$2.88M of LLY shares in the open market
12. Jun 10, 2026Congress · 1 personMembers of Congress: 2 purchases
13. Jul 10, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
14. Jul 13, 2026FDAFDA drug approval: Verzenio
15. Jul 14, 2026FDAFDA drug approval: Retevmo
16. Jul 14, 2026FDAFDA drug approval: Retevmo
17. Jul 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.6%

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 189 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Sen. Alan Armstrong

• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at KKR & Co. (KKR)Jul 21, 2026
• Senate eFD periodic transaction report at Globe Life (GL)Jul 21, 2026
• Senate eFD periodic transaction report at Copart (CPRT)Jul 21, 2026

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Eli Lilly

• SEC Form 144Oct 7, 2026
• USAspending.gov award recordSep 1, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 25, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 13F-HRAug 18, 2026

Everything OQRO holds on this company is on its LLY page.